Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: DIA
Live from DIA: Bridging the Data Gap
Image via CrunchBase
At the Drug Information Association’s annual meeting, Pharm Exec got a few minutes to talk with a little software company named Microsoft’s about its work in creating integration between electronic data capture [EDC] and electronic health records [EHR], and its new Amalga technology.
Electronic Data Capture Integration
“I don’t think electronic data capture has evolved [...]
Posted in Technology Also tagged Amalga, Electronic Data Capture, Health Records, Microsoft Leave a comment
Live from DIA: FDA Warning Letters Stir More Questions Than Answers
A panel of regulators from FDA’s Division of Drug Marketing, Advertising, and Communications were taken to task, this morning at the Drug Information Association’s annual meeting, for 14 warning letters levied on drug companies for not including risk information in online search ads.
A Sanofi Aventis employee complained about the 14 warning letters and asked why [...]
Posted in Advertising, Regulatory Also tagged DDMAC, FDA, Marketing, new media, Search, Warning Letters 1 Comment

Building a Better Brief Summary